hepatic steatosis phenotype
Evidence from:
primary |
all sources
Related entities (5)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Cyp2a5 | protective_against | hepatic steatosis | — | 1 |
| Cyp2a5 | risk_factor_for | hepatic steatosis | — | 1 |
| Fgf21 | protective_against | hepatic steatosis | — | 3 |
| obesity | associated_with | hepatic steatosis | — | 1 |
| PPARα−/− mice | risk_factor_for | hepatic steatosis | — | 2 |
Mentioned in (4)
Papers in which this entity is mentioned.
- Alcohol Exposure May Increase Prenatal Choline Needs Through Redirection of Choline into Lipid Synthesis Rather than Methyl Donation. (2025)
- Alcohol and Immunology: Mechanisms of multi-organ damage. Summary of the 2022 alcohol and Immunology research interest group (AIRIG) meeting. (2023)
- Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
- CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. (2019)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| steatosis | phenotype | 21 | 65 |
| hepatic steatosis | phenotype | 17 | 70 |
| liver steatosis | phenotype | 3 | 7 |
| centrilobular steatosis | phenotype | 1 | 1 |
| benign steatosis | phenotype | — | — |